Atrium Therapeutics, Inc. Common Stock Tangible Net Worth Ratio
Atrium Therapeutics, Inc. Common Stock tangible net worth ratio. Atrium Therapeutics, Inc. Common Stock (RNA) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($207.29 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Atrium Therapeutics, Inc. Common Stock strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Atrium Therapeutics, Inc. Common Stock (2011–2025)
Tangible net worth ratio of Atrium Therapeutics, Inc. Common Stock from 2011 to 2025. This chart shows how Atrium Therapeutics, Inc. Common Stock's Tangible Net Worth Ratio has changed across 9 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $207.29 Million with intangible assets of $0.00 USD. See working capital to net assets of Atrium Therapeutics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Atrium Therapeutics, Inc. Common Stock Tangible Net Worth Ratio by Year (2011–2025)
Atrium Therapeutics, Inc. Common Stock tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Atrium Therapeutics, Inc. Common Stock from 2011 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Atrium Therapeutics, Inc. Common Stock (RNA) total market value.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $207.29 Million | $0.00 | $278.35 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $1.42 Billion | $0.00 | $1.56 Billion | ▲ +0.0 pp |
| 2023 | 100.0% | $500.76 Million | $0.00 | $628.55 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $578.08 Million | $0.00 | $638.80 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $381.43 Million | $0.00 | $427.58 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $306.22 Million | $0.00 | $333.90 Million | ▲ +1.2 pp |
| 2013 | 98.8% | $87.10 Million | $1.04 Million | $125.10 Million | ▲ +4.4 pp |
| 2012 | 94.4% | $20.54 Million | $1.15 Million | $62.41 Million | ▲ +28.8 pp |
| 2011 | 65.6% | $3.41 Million | $1.17 Million | $32.68 Million | — |